Related Experiment Video
Updated: Mar 22, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Autolytic Activity and Plasma Binding Study of Aap, a Novel Minor Autolysin of Streptococcus pneumoniae
Ramina Mahboobi1, Davoud Afshar1, Mohammad Reza Pourmand1
1Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
Pneumococcal autolysins are enzymes involved in cell wall turnover and cellular division physiologically. They have been found to be involved in the pneumococcus pathogenesis. The aim of this study was to identify the autolytic activity of Spr1754 as a novel protein of Streptococcus pneumoniae. Moreover, the binding of the recombinant protein to plasma proteins was also determined. The spr1754 gene was amplified by PCR and cloned into the pET21a(+) prokaryotic expression vector. The constructed pET21a(+)/spr1754 recombinant plasmid was transformed into E. coli Origami (DE3) and induced using IPTG. The recombinant protein of Spr1754 was purified by Ni-NTA affinity chromatography and confirmed by SDS-PAGE and Western blot analysis using anti-His tag monoclonal antibody. Autolytic activity and the ability of the recombinant protein in binding to plasma proteins were performed using zymogram analysis and western blot, respectively. The spr1754 with expected size was cloned and overexpressed in Escherichia coli Origami (DE3), successfully. After purification of the Spr1754 recombinant protein, the autolytic activity was observed by zymography. Of the four plasma proteins used in this study, binding of lactoferrin to Spr1754 recombinant protein was shown. The Spr1754 recombinant protein has a bifunctional activity, i.e., as being autolysin and lactoferrin binding and designated as Aap (autolytic/ adhesion/ pneumococcus). Nevertheless, characterization of the Aap needs to be followed using gene inactivation and cell wall localization.
Insights
This study identifies Spr1754 from Streptococcus pneumoniae as a novel bifunctional autolysin and lactoferrin-binding protein, named Aap. Further research is needed to fully characterize this pneumococcus protein.
Area of Science:
- Microbiology
- Enzymology
- Protein Biochemistry
Background:
- Pneumococcal autolysins are crucial for cell wall dynamics and pathogenesis.
- Understanding novel autolysins aids in developing therapeutic strategies against Streptococcus pneumoniae infections.
Purpose of the Study:
- To investigate the autolytic activity of the novel protein Spr1754 from Streptococcus pneumoniae.
- To determine the binding capacity of the recombinant Spr1754 protein to plasma proteins.
Main Methods:
- Gene amplification (PCR) and cloning of spr1754 into a prokaryotic expression vector.
- Overexpression in E. coli Origami (DE3) and purification via Ni-NTA affinity chromatography.
- Assessment of autolytic activity using zymography and plasma protein binding via Western blot.
Main Results:
- Successful cloning, overexpression, and purification of the recombinant Spr1754 protein.
- Demonstration of autolytic activity of Spr1754 via zymography.
- Identification of lactoferrin binding to the recombinant Spr1754 protein, suggesting a bifunctional role.
Conclusions:
- The novel protein Spr1754 exhibits bifunctional activity as an autolysin and a lactoferrin-binding protein, designated Aap (autolytic/adhesion/pneumococcus).
- Further studies involving gene inactivation and cell wall localization are required for comprehensive characterization of Aap.
More Related Videos
08:47Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017